Recruiting

  1. ALOFT-IPF
    A Multicentre, Randomised, Double-blind, Placebo-controlled, Phase 3 Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants with Idiopathic Pulmonary Fibrosis (IM027-068).
    Trial Category: Featured Trial Age Group: Over 40 years Trial Disease Type: Idiopathic Pulmonary Fibrosis (IPF) Trial Participant Type: Patient Trial Phase: Phase 3 Trial Location: NSW QLD VIC WA Trial Status: Recruiting Trial Type: Interventional
  2. ALOFT-PPF
    A Multiicentre, Randomised, Double-blind, Placebo-controlled, Phase 3 Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants with Progressive Pulmonary Fibrosis (IM027-1015).
    Trial Category: Featured Trial Age Group: Over 21 years Trial Disease Type: Progressive Pulmonary Fibrosis Trial Participant Type: Patient Trial Phase: Phase 3 Trial Location: NSW QLD VIC WA Trial Status: Recruiting Trial Type: Interventional
  3. ASPIRE IPF Study
    A Randomised, Double-blind, Placebo-controlled, Parallel-group, Multicentre Trial Evaluating the Efficacy and Safety of 2 Doses of Buloxibutid Over 52 Weeks in People with Idiopathic Pulmonary Fibrosis.
    Trial Age Group: Over 40 years Trial Disease Type: Idiopathic Pulmonary Fibrosis (IPF) Trial Participant Type: Patient Trial Phase: Phase 2 Trial Location: NSW QLD SA VIC Trial Status: Recruiting Trial Type: Interventional
  4. BI 1819479 Study
    This study is to find out whether a medicine called BI 1819479 helps people with Idiopathic Pulmonary Fibrosis (IPF).
    Trial Age Group: Over 40 years Trial Disease Type: Idiopathic Pulmonary Fibrosis (IPF) Trial Participant Type: Patient Trial Phase: Phase 2 Trial Location: ACT New Zealand NSW TAS VIC Trial Status: Recruiting Trial Type: Interventional
  5. CORAL
    Cough Reduction in IPF with nalbuphine ER.
    Trial Age Group: Over 18 years Trial Disease Type: Idiopathic Pulmonary Fibrosis (IPF) Trial Participant Type: Patient Trial Phase: Phase 2 Trial Location: NSW SA VIC WA Trial Status: Recruiting Trial Type: Interventional
  6. Avalyn AP01 MIST
    A Study Evaluating the Safety and Efficacy of AP01 in Participants with Progressive Pulmonary Fibrosis (PPF).
    Trial Age Group: Over 18 years Trial Disease Type: Progressive Fibrosing Interstitial Lung Diseases (PF-ILD) Progressive Pulmonary Fibrosis Trial Participant Type: Patient Trial Phase: Phase 2 Trial Location: ACT New Zealand NSW VIC WA Trial Status: Recruiting Trial Type: Interventional
  7. REBUILD-SM Trial
    A Randomised Clinical Trial of a digital Self-Management package for people with Interstitial Lung Disease (REBUILD-SM trial).
    Trial Age Group: Over 18 years Trial Disease Type: Interstitial Lung Disease (ILD) Trial Participant Type: Patient Trial Phase: Not applicable Trial Location: NSW QLD VIC Trial Status: Recruiting Trial Type: Interventional
  8. SNDX-6352-0506
    A 26-Week, Randomized, Double-Blind, Placebo-Controlled, Multi-center Study to Evaluate the Efficacy, Safety, and Tolerability of Axatilimab in Subjects with Idiopathic Pulmonary Fibrosis (IPF).
    Trial Disease Type: Idiopathic Pulmonary Fibrosis (IPF) Trial Participant Type: Patient Trial Phase: Phase 2 Trial Location: NSW QLD VIC WA Trial Status: Recruiting Trial Type: Interventional
  9. GRIPF
    Genetic Research in Idiopathic Pulmonary Fibrosis.
    Trial Age Group: Over 18 years Under 18 years Trial Disease Type: Idiopathic Pulmonary Fibrosis (IPF) Pulmonary Fibrosis (PF) Trial Participant Type: Patient and Carer Trial Phase: Not applicable Trial Location: NSW QLD SA VIC Trial Status: Recruiting Trial Type: Observational